Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.7B | 4.7B | 4.4B | 5.2B |
Cost of revenue | 2.0B | 1.8B | 2.0B | 1.9B |
Gross profit | 2.8B | 2.9B | 2.4B | 3.3B |
Operating expense | ||||
Research & development | 164.5M | 145.1M | 283.1M | 150.8M |
Selling general and admin | 1.1B | 1.1B | 1.1B | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | 1.5B | 1.7B | 1.0B | 2.1B |
Non operating interest income | ||||
Income | 31.9M | 23.2M | 30.1M | 26.4M |
Expense | 133.1M | 140.8M | 139.3M | 141.5M |
Other income expense | — | — | — | — |
Pretax income | 827.3M | 1.7B | 1.5B | 1.9B |
Tax provision | 99.0M | 307.0M | 361.8M | 332.9M |
Net income | 728.3M | 1.4B | 1.1B | 1.6B |
Basic EPS | 2.8 | 5.5 | — | 6.0 |
Diluted EPS | 2.8 | 5.4 | — | 6.0 |
Basic average shares | 259.2M | 262.5M | — | 261.7M |
Diluted average shares | 261.0M | 264.1M | — | 263.0M |
EBITDA | 1.3B | 2.2B | 2.0B | 2.4B |
Net income from continuing op. | 827.3M | 1.7B | 1.5B | 1.9B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |